SEC CIK 1848218
Sawicki Mark W
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| CYRXview stock → | 102,356 | 2026-03-23 |
Position History — CYRX
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — CYRX
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-03-23 | Open-market sale | 1,341 | $8.18 | 102,356 |
| 2026-03-16 | Open-market sale | 3,235 | $8.00 | 103,697 |
| 2026-03-14 | Grant / award (derivative) | 68,534 | $0.00 | 68,534 |
| 2026-03-14 | Grant / award | 22,845 | $0.00 | 106,932 |
| 2025-03-24 | Open-market sale | 1,349 | $6.94 | 84,087 |
| 2025-03-17 | Open-market sale | 2,092 | $6.29 | 85,436 |
| 2025-03-14 | Grant / award (derivative) | 24,000 | $0.00 | 24,000 |
| 2025-03-14 | Grant / award | 9,000 | $0.00 | 87,528 |
| 2025-03-10 | Open-market sale | 1,583 | $4.88 | 78,528 |
| 2025-03-09 | Option exercise (derivative) | 2,667 | $0.00 | 0 |
| 2025-03-09 | Option exercise | 2,667 | $0.00 | 80,111 |
| 2024-03-25 | Open-market sale | 1,367 | $17.54 | 77,444 |
| 2024-03-15 | Grant / award (derivative) | 11,500 | $0.00 | 11,500 |
| 2024-03-15 | Grant / award | 5,750 | $0.00 | 78,811 |
| 2024-03-15 | Open-market sale | 1,312 | $15.43 | 73,061 |
| 2024-03-11 | Open-market sale | 1,418 | $16.35 | 74,373 |
| 2024-03-09 | Option exercise (derivative) | 2,666 | $0.00 | 2,667 |
| 2024-03-09 | Option exercise | 2,666 | $0.00 | 75,791 |
| 2023-09-12 | Option exercise (derivative) | 1,000 | $0.00 | 89,000 |
| 2023-09-12 | Option exercise | 1,000 | $12.79 | 73,125 |
| 2023-03-22 | Grant / award (derivative) | 20,910 | $0.00 | 20,910 |
| 2023-03-22 | Grant / award | 10,455 | $0.00 | 72,125 |
| 2023-03-15 | Open-market sale | 1,362 | $20.79 | 61,670 |
| 2023-03-13 | Open-market sale | 1,476 | $20.14 | 63,032 |
| 2023-03-09 | Option exercise (derivative) | 2,667 | $0.00 | 5,333 |
| 2023-03-09 | Option exercise | 2,667 | $0.00 | 64,508 |
| 2022-03-14 | Grant / award (derivative) | 20,910 | $0.00 | 20,910 |
| 2022-03-14 | Grant / award | 10,455 | $0.00 | 61,841 |
| 2022-03-09 | Option exercise (derivative) | 2,667 | $0.00 | 8,000 |
| 2022-03-09 | Open-market sale | 1,410 | $31.05 | 51,386 |
| 2022-03-09 | Option exercise | 2,667 | $0.00 | 52,796 |
| 2021-08-11 | Option exercise (derivative) | 16,577 | $0.00 | 51,423 |
| 2021-08-11 | Option exercise (derivative) | 77,625 | $0.00 | 0 |
| 2021-08-11 | Open-market sale | 3,172 | $59.11 | 52,650 |
| 2021-08-11 | Open-market sale | 2,521 | $59.83 | 50,129 |
| 2021-08-11 | Option exercise | 77,625 | $7.80 | 113,698 |
| 2021-08-11 | Option exercise | 16,577 | $8.65 | 130,275 |
| 2021-08-11 | Open-market sale | 74,453 | $58.37 | 55,822 |
| 2021-03-10 | Option exercise (derivative) | 7,231 | $0.00 | 0 |
| 2021-03-10 | Option exercise | 7,231 | $1.87 | 37,573 |
| 2021-03-10 | Open-market sale | 3,974 | $54.65 | 45,430 |
| 2021-03-10 | Option exercise | 11,342 | $3.07 | 30,342 |
| 2021-03-10 | Option exercise | 11,831 | $3.21 | 49,404 |
| 2021-03-10 | Open-market sale | 9,357 | $55.33 | 36,073 |
| 2021-03-09 | Grant / award (derivative) | 21,333 | $0.00 | 21,333 |
| 2021-03-09 | Grant / award (derivative) | 10,667 | $0.00 | 10,667 |
| 2021-02-25 | — | — | — | 19,000 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.